GUIDED THERAPEUTICS INC 4

4 · GUIDED THERAPEUTICS INC · Filed Jul 17, 2015

Form 4

Period: 2015-05-29

Director

Transactions

Purchase
Common Stock
2015-06-29+5,682→ 696,748 total
Purchase
Tranche A Warrants
2015-06-19+18,382→ 18,382 total
Exercise: $0.10From: 2013-05-22Exp: 2018-05-22→ Common Stock (18,382 underlying)
Sale
Tranche A Warrants
2015-06-19−18,382→ 0 total
Exercise: $1.08From: 2013-05-22Exp: 2018-05-22→ Common Stock (18,382 underlying)
Award
Options
2015-05-29+600,000→ 1,255,000 total
Exercise: $0.10From: 2015-05-29Exp: 2025-05-28→ Common Stock (600,000 underlying)
Sale
Tranche B Warrants
2015-06-19−189,889→ 0 total
Exercise: $0.10From: 2013-05-22Exp: 2018-05-22→ Common Stock (189,889 underlying)
Purchase
Tranche B Warrants
2015-06-19+189,889→ 189,889 total
Exercise: $0.09From: 2013-05-22Exp: 2018-05-22→ Common Stock (189,889 underlying)

Footnotes (3)

[F1]On June 30, 2015, the reporting person disposed of warrants to purchase common stock in exchange for new warrants to purchase common stock and shares of common stock in an exchange with the issuer.
[F2]These shares were granted as dividend on the issuer's Series B preferred stock.
[F3]These options to purchase common stock were granted under the Guided Therapeutics, Inc. 1995 Stock Plan as amended; as 2015 director's fees, in lieu of cash. The options are 100% vested.

Documents

1 file